SPINAKER Alfa

SPINAKER Alfa is a Polish seed-stage VC headquartered in Lodz, with disclosed activity in digital health, MedTech, and AI-enabled healthcare. The fund operates within the Polish public-private VC ecosystem common in Central and Eastern Europe, where national co-investment programs, regional development funds, and private capital combine to underwrite early-stage companies. There is no standalone website associated with the firm in the source record, which is consistent with smaller regional Polish funds that operate primarily through LinkedIn and direct relationships.

The thesis indicated by the source data is seed-stage Polish digital health, MedTech, and AI-in-healthcare companies. For founders, that translates to a relevant target if you are domiciled or operating substantially in Poland and your company sits in physician-facing software, clinical AI, regulated medical devices, or care delivery technology. Portfolio companies are not disclosed in the input record, and the absence of a primary website means founders should treat the LinkedIn presence as the first-line reference and request a deal list directly during initial outreach.

Check size is not specified in the source record. The firm operates at seed stage only, with Polish geographic scope. Polish public-private seed structures typically deploy in the EUR 200K to EUR 1.5M range and frequently require a Polish operating entity or substantive Polish nexus, so founders outside that footprint should confirm fit before investing meaningful pitch time.

Named team members are not provided in the input record. LinkedIn is the only documented channel and is the right starting point for partner identification.

Approach SPINAKER Alfa when you are a Polish-domiciled or Polish-nexus founder raising a seed round in digital health, MedTech, or healthcare AI, and you want a regional fund familiar with Polish public co-investment vehicles, the National Centre for Research and Development pathway, and the Central European clinical commercialization context. They are not the right call for US-only founders, growth-stage rounds, or non-healthcare AI plays. The right entry is a warm introduction via a Polish founder in the digital health ecosystem, a Lodz-area startup hub, or an angel familiar with the firm. Pitch in plain terms, with the regulatory pathway, the clinical evidence plan, and the Polish or Central European go-to-market clearly articulated, because regional funds underwrite on operational realism rather than US-style narrative.